Results 41 to 50 of about 13,168 (257)

Ergotamine-induced acute tubulo-interstitial nephritis

open access: yesSaudi Journal of Kidney Diseases and Transplantation, 2013
Ergotamine has been used for the treatment of migraine for many years, and its use in adults is considered to be safe and effective. In this report, we present a 22-year-old female patient, a known case of migraine, who was on ergotamine tartrate and ...
Maryam Pakfetrat   +6 more
doaj   +1 more source

Effective Improvement of Symptoms in Patients with Acute Migraine by GR43175 Administered in Dispersible Tablets [PDF]

open access: yes, 1989
GR43175, a selective 5-HT1-like agonist, was administered as oral dispersible tablets in an open, uncontrolled dose-ranging study to assess its efficacy as an agent for acute migraine.
Bayliss, E.M.   +2 more
core   +1 more source

Oclusão arterial aguda por derivados da ergotamina Acute arterial occlusion caused by ergotamine derivatives

open access: yesJornal Vascular Brasileiro, 2009
Os derivados da ergotamina compõem diversas drogas amplamente utilizadas no tratamento de ataques agudos de migrânea. A intoxicação por estas substâncias resulta geralmente de sua administração crônica, promovendo sintomas secundários ao espasmo arterial
Edison Barreto de Souza   +1 more
doaj   +1 more source

Functional Characterization of the Prejunctional Receptors Mediating the Inhibition by Ergotamine of the Rat Perivascular Sensory Peptidergic Drive.

open access: yesACS Chemical Neuroscience, 2019
Calcitonin gene-related peptide (α-CGRP) released from perivascular sensory nerves induces decreases in diastolic blood pressure (DBP). Experimentally, this can be shown by spinal thoracic (T9-T12) electrical stimulation of these afferent fibers. Because
A. González-Hernández   +4 more
semanticscholar   +1 more source

Exploring a structural protein-drug interactome for new therapeutics in lung cancer [PDF]

open access: yes, 2014
The pharmacology of drugs is often defined by more than one protein target. This property can be exploited to use approved drugs to uncover new targets and signaling pathways in cancer.
Bum-Erdene, Khuchtumur   +12 more
core   +1 more source

Scientometric assessment of drugs for chronic pain, 1979–2013: rapid growth of publications, paucity of successful drugs [PDF]

open access: yes, 2014
The aim of this study was to find signs of progress in the pharmacotherapy of chronic pain over the past 35 years using scientometric analysis. The following scientometric indices were used: 1) popularity index, representing the share of articles on a ...
Kissin, Igor
core   +1 more source

Analysis of Ergot Alkaloids

open access: yesToxins, 2015
The principles and application of established and newer methods for the quantitative and semi-quantitative determination of ergot alkaloids in food, feed, plant materials and animal tissues are reviewed.
Colin Crews
doaj   +1 more source

Colon Ischaemia Induced by Amoxicillin-related Anaphylactic Shock

open access: yesEuropean Journal of Case Reports in Internal Medicine, 2021
Colon ischaemia is the most frequent type of ischaemia of the digestive tract. It is more common among the elderly, especially patients with haemodynamic disturbance.
Nuno Melo   +4 more
doaj   +1 more source

Network Pharmacology and Experimental Verification to Explore the Potential Mechanism of Yin-Huo-Tang for Lung Adenocarcinoma Recurrence

open access: yesDrug Design, Development and Therapy, 2022
Dianna Liu,1 Shicheng Lin,2 Yuan Li,2 Tian Zhou,1 Kaiwen Hu,1 Quanwang Li1 1Oncology Department, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, 100071, People’s Republic of China; 2Graduate School, Beijing University of Chinese ...
Liu D, Lin S, Li Y, Zhou T, Hu K, Li Q
doaj  

Efficacy and safety of rimegepant for the preventive treatment of migraine in Japan: A double-blind, randomized controlled trial. [PDF]

open access: yesHeadache
Plain Language Summary: This study tested the effectiveness of rimegepant for migraine prevention in Japan. Results showed that rimegepant was more effective than placebo in reducing monthly migraine days, with very few adverse effects. These results support the previous findings from a clinical study conducted in the United States and broaden them to ...
Kitamura S   +11 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy